Search

everythinglearnresearchcommunity

for

Search:↓

Sex hormones affect liver fat and metabolic health differently in men and women.

Oxidative stress worsens PCOS by damaging cells and disrupting metabolism, suggesting antioxidant treatments might help.

Hormone imbalance is linked to Hidradenitis Suppurativa, a skin condition, and treatments like anti-androgenic therapy and metformin can help. It's also suggested to check patients for insulin resistance and Polycystic Ovary Syndrome.

Nanomaterials could improve PCOS treatment by delivering drugs more effectively with fewer side effects.

Alopecia areata patients have a higher risk of subclinical atherosclerosis, and carotid ultrasound can help assess their cardiovascular risk.

PCOS causes infertility mainly due to hormonal imbalances, insulin resistance, and chronic inflammation.

Heat Shock Proteins are important in the development of Polycystic Ovarian Syndrome and could be targets for new treatments.

MicroRNAs could be key biomarkers and therapeutic targets for PCOS.

Changes in gut bacteria can contribute to the development of Polycystic Ovary Syndrome (PCOS), affecting metabolism, immunity, and causing inflammation. Treatments may involve adjusting these factors.

Some skin conditions, like psoriasis and early-onset baldness, may indicate metabolic syndrome, and others are linked to diabetes risk and cardiovascular issues.

The free androgen index varies among women with different types of PCOS.

High uric acid levels are more common in PCOS patients, especially those with androgenic PCOS, and are linked with increased cardiovascular risk and other metabolic issues.

Men with male pattern baldness have higher blood sugar, bad cholesterol, and ZAG protein levels than healthy men.

Tirzepatide might help manage PCOS in obese patients but needs more research to confirm safety and effectiveness.

A 16-year-old girl with HAIR-AN syndrome was treated with lifestyle changes and medications to manage her condition.

New treatments are needed for PCOS that target its genetic, hormonal, and metabolic causes.

Polycystic ovary syndrome (PCOS) was first described in 1721, officially diagnosed in the 1990s, and is now known to be partly genetic and linked to insulin resistance, with increased risk of cardiovascular disease and carbohydrate metabolism issues.

The document concludes that a systematic approach is crucial to identify causes of androgen excess in women beyond the most common cause, Polycystic ovary syndrome (PCOS).

Ovarian hyperthecosis can cause symptoms even with normal testosterone levels, and surgery can improve these symptoms.

Quercetin may help improve symptoms of polycystic ovary syndrome.

Fenugreek can help with PCOS symptoms, but metformin is more effective overall.

Eating a Mediterranean diet and taking certain supplements may improve symptoms of PCOS.

Vitamin D is needed for metformin to lower prolactin effectively.

More young women are getting diagnosed with PCOS, which can lead to other health problems, but early treatment can help.

The chapter concludes that diet and lifestyle changes can help manage PCOS symptoms and improve fertility.

PCOS affects many aspects of health, not just fertility, and needs comprehensive treatment.

Early diagnosis and treatment of PCOS are crucial to reduce health risks and costs.

Early balding in young Indian men may indicate a higher risk of metabolic syndrome and potential heart disease.

Obese women with PCOS have more cardiovascular risk factors, and waist-to-stature ratio is a better health marker than waist-to-hip ratio.

Belly fat is the main predictor of nonalcoholic fatty liver disease in both women with Polycystic ovary syndrome and healthy women.